SCIESCOPUSQ1
Experimental Hematology & Oncology
BMC, United Kingdom
Experimental Hematology & Oncology is an academic journal published by BMC (United Kingdom). Identifiers: eISSN 2162-3619. Indexed in SCIE, SCOPUS. Metrics: JIF 13.5, CiteScore 14.3, SJR 3.092, SNIP 1.69. Subject areas: HEMATOLOGY, ONCOLOGY. tlooto lists 1,050 papers from this journal.
CiteScore
14.30
Scopus citation metric
SJR
3.092
SCImago rank
SNIP
1.69
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2162-3619
- Abbreviation
- EXP HEMATOL ONCOL
- Publisher
- BMC
- Country
- United Kingdom
Web of Science categories
SCIEHEMATOLOGY, ONCOLOGY
Scopus ASJC categories
1306 Cancer Research2720 Hematology2730 Oncology
Keywords
Oncology | Hematology
Papers in this journal
Recent papers
- Biology-informed risk stratification of glioblastoma by integrating MRI-based intratumoral heterogeneity with clinical features: a multicenter validation study.
2026
- Crosstalk between ferroptosis and extracellular vesicles in cancer: from interaction to clinical application
2026 · 1 citations
- From Amphiphiles to mRNA platforms: emerging vaccination strategies for pancreatic cancer
2026
- Mutation rates in main tumour driver genes predict prognosis in patients with superficial spreading or nodular primary melanoma: results from the CARAMEL study by the Italian Melanoma Intergroup (IMI)
2026
- Gastric and upper gastrointestinal oncology: integrating breakthroughs from prevention to precision therapeutics
2026 · 1 citations
Most cited papers
- CD19: a biomarker for B cell development, lymphoma diagnosis and therapy
2012 · 522 citations
- Complex roles of cAMP–PKA–CREB signaling in cancer
2020 · 399 citations
- CD44 as a tumor biomarker and therapeutic target
2020 · 311 citations
- CD133: a stem cell biomarker and beyond
2013 · 307 citations
- Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
2012 · 281 citations